Official facilitator of


basal cell carcinoma treatment in Israel

Basal cell carcinoma (basal cell carcinoma) - one of the most common types of skin cancer. Of cancer of the skin basal cell carcinoma is the most favorable prognosis. Tumor affects the surface layers, it is extremely seldom penetrate into adjacent structures, usually if left untreated. Most often, the development of basal cell carcinoma is slow, without symptoms and metastases in other organs and tissues.

We will provide the high level of treatment at Assuta , Offering logistics services package for $ 280. Read more about the benefits of working with us here .

Advantages of basal cell carcinoma treatment in Israel in the clinic Assuta:

  • Modern medical equipment clinic.
  • Services leading Israeli doctors, the possibility of the doctor of choice.
  • The use of the latest developments, technologies and medicines.
  • The high standards of treatment.
  • Reasonable cost compared with Western countries and Europe - an average of 20-30%.

Prices of basal cell carcinoma treatment in Israel

We give an estimated cost of diagnostic and therapeutic procedures in Assuta:

  1. Oncologist Consultation - $ 600
  2. oncology consultation - a dermatologist - 560 dollars
  3. Blood test - from $ 80
  4. Total (expanded) blood test - $ 260
  5. Histological examination - $ 680
  6. Resection (removal of the tumor) - $ 5 300

For more information, fill in the request form, call us or email to the specified email address.

stage basal cell carcinoma

basal cell carcinoma treatment in Israel, the priceThe staging system - the standard method, which determines how far the cancer has spread. On the basis of these data to make predictions and choose the best treatment options.

AJCC system proposed committee (American Joint Committee on Cancer). In setting the stage basal cell carcinoma accounted for the following items:

  • T indicates the tumor criteria: the size, location, distribution in the skin and surrounding tissues.
  • N indicates the growths on the adjacent lymph nodes.
  • M notes that there are secondary centers - metastases in distant organs.

Category T

Tx - the main tumor can not be assessed.

T0 - no evidence of primary tumor.

Tis - the tumor is limited to the outer layer of the skin.

T1 tumor diameter less than 2 cm, it has no or only one indication of increased mitotic rate, which indicates the inclination of basal cell carcinoma to grow and spread.

T2 - neoplasms diameter greater than 2 cm, it has a large number of propagation characteristics in the body.

T3 - the tumor has grown into the facial bones (jaw) or the bone tissue around the eyes.

T4 - tumor infiltrated into other bones in the body or in the base of the skull.

Signs of high risk of basal cell carcinoma of categories T1 and T2.

  • Tumor thickness more than 2 mm.
  • Neoplasm has invaded into the lower layers of the dermis or subcutaneous fat.
  • Perineural invasion occur when a tumor grows in the nerve tissue.
  • Under the microscope, the cells look abnormal poorly differentiated or undifferentiated.
  • Basal cell carcinoma grows in the ear area.

Category N

Possible values ​​for N:

NX: it is impossible to assess the nearby lymph nodes.

N0: no spread to surrounding lymph nodes.

N1: the tumor has spread to a nearby lymph node, which is located in the same place, where the primary focus is not more than 3 centimeters in diameter.

N2a: bazalioma grown on neighboring lymph node around the main tumor, from 3 to 6 centimeters in diameter.

N2b: tumor has spread to several neighboring lymph nodes near the primary tumor to 6 centimeters in diameter.

N2C: bazalioma penetrated into neighboring lymph nodes on the other side of the main body of the tumor, its dimensions do not exceed 6 cm in diameter.

N3: Tumor invades any neighboring lymph nodes, the size of which over 6 cm in diameter.

Category M

The values ​​of M:

M0: pathological lesions are not penetrated to distant organs.

M1: the malignant cells have spread to distant organs.

stage grouping

At this stage, general categories are combined T, N, and M. The patients with earlier stage basal cell carcinoma have a better prognosis for a cure.

Stage 0 Tis, N0, M0.

Stage I T1, N0, M0

Stage II T2, N0, M0

III stadiyaT3, N0, M0

T1-T3, N1, M0

IV stage T1-T3, N2, M0

Any T, N3, M0

T4, any N, M0

Any T, any N, M1

Diagnosis of basal cell carcinoma in Israel

The patient is initially directed to the dermatologist for consultation. The clinic Assuta basal cell carcinoma is most often diagnosed in the primary survey. The final diagnosis is confirmed only after a series of laboratory tests. Investigated blood retrieved by the intended biopsy samples of the tumor tissue.

After receiving the results of research selected the most appropriate in this case, the tactics of treatment of basal cell carcinoma in Israel. Assuta Hospital doctors determine stages of treatment, its scope and duration. Full diagnostics takes 1-3 days.

Methods of treatment of basal cell carcinoma in Israel

Selection of a particular method of therapy is conducted individually and depends on the stage of the tumor, the age and general health of the patient.

For the treatment of cancer in Israel methods are used: surgery, radiation therapy, chemotherapy, targeted therapy and other methods.

All of these methods of treatment of basal cell carcinoma in Israel - effective. The probability of relapse after surgery Mos is less than 5% to 15% - with other treatment methods, depending on the tumor size. Neoplasms small volume rarely recur. Even the return of basal cell carcinoma is well treated.

Basal cell carcinoma is curable, but the emphasis on primary care as well as an opportunity to destroy the abnormal cells in the body at the first attempt higher than in the secondary circulation in the clinic. Therefore, the choice of doctor is very important, his professionalism and expertise, experience and knowledge should be beyond reproach. Principles that comply in their activities leading oncologists of Israel, are as follows:

  1. Total removal of basal cell carcinoma.
  2. Preservation of normal tissue.
  3. Saving organ functionality.
  4. Optimal cosmetic result.

The most important goal - to rid the patient of the tumor. Basal cell carcinomas are slow growing and rarely metastasize, but this factor should not blunt the patient and physician attention from the dangers posed by cancer. Among the treatments bazilomy in Israel are:


One of the most common treatments. Processing undergo small tumors, while freezing on average lasts 30 seconds. The therapy is performed under local anesthesia. In the removal of carcinoma are subsequently blisters, scabs. Healing lasts up to 6 weeks after it left only a small star-shaped, slightly concave scar white. Cryosurgery is often used for superficial basal cell carcinoma on his back. However, the method is absolutely not suitable for the treatment of recurrent basal cell carcinomas. If it is carried out on the carcinoma than 1 cm in diameter, or about the nodular lesions, cryosurgery can be combined with curettage.

Curettage and elektrofulguratsiya

It involves scraping most of the tumor a special tool, similar to a small spoon with a long handle. Then the tumor bed is treated electric current to burn surrounding tissue around 1 mm. The procedure requires 3 cycles of practice for small nodular tumors. Not applicable for the removal of tumors of the face.

Excision and Mohs Surgery

This treatment gives the advantage to carry out the pathological analysis provides an assessment of cancer tissues. Using classicalsurgery successfully treated 98% of basal cell carcinoma. Micrographic surgery Mohs - is the gold standard treatment of basal cell carcinoma, which shows the highest results of therapy. Of course, it is more expensive than other methods and requires a long time.

It is used for tumors on the face, ears, scalp, neck, where the preservation of healthy tissue is most important and where important histological control. The tumor is excised layers with a painstaking study of residual materials in order to prevent the residue of the affected cells in the body. The effectiveness of treatment of basal cell carcinoma in Israel this method reaches 99% at the initial treatment, and 97% of oncology for the treatment of recurrent tumors. Almost always performed under local anesthesia.

radiation therapy

Radiation therapygives good results in the treatment of most types of basaliomas. It takes 15-20 visits to the doctor within 3-4 weeks. For elderly patients with multiple basal cell carcinoma is the ideal treatment option. However, a particular treatment regimen selected after examination of additional factors.

Laser and other technologies

Carbon dioxide laser is most commonly used in the treatment of basal cell carcinoma in Israel instead of scraping and fulguration for the treatment of multiple basaliomas. The disadvantage of the method lies in the fact that after the laser beam is not possible to take a sample of abnormally altered tissue for histological analysis.

It is also used for the therapy of phototherapy, but as an independent method is rarely used. Use other methods of treatment, including specialized drugs outdoor use. Are taken into consideration such factors as:

  • the size of the lesion;
  • distinctness, sharpness and clarity of tumor boundaries;
  • primary or secondary neoplasms nature (whether the treatment carried out previously);
  • anatomic location of basal cell carcinoma;
  • subtype of the tumor;
  • age, cosmetic results and so on.

If the cosmetic result is not important, applied cryosurgery, curettage, fulguration. For younger patients is indispensable the use of robotic technology, classical excision. The vast majority of basal cell carcinoma, doctors cut out without general anesthesia, since it is not required.

Innovative drugs in the treatment of basal cell carcinoma in Israel

treatment of basal cell carcinomaOdomzo (sonidegib) received FDA approval for the treatment of locally advanced forms of basal cell carcinoma. It recommended for patients who can not undergo surgery or radiation therapy; at relapse, when the above methods used previously. According to the results of clinical trials, 58% of patients had a reduction of tumor.

ERIVEDGE® (Vismodegib) prescribed for the treatment of adults with metastatic basal cell carcinoma, a locally advanced recurrent basal cell carcinomas, with contraindications to surgery or radiation.

Assuta Hospital offers innovative treatments for basal cell carcinoma under the supervision of the best doctors in Israel.


"I worked as a dermatologist and surgeon for many years. And she did not just make the diagnosis for patients. But what I ever get sick myself, I did not expect. In 2006, I was diagnosed ... On the side of the nose appeared tight pink bump. He never took seriously worried. He does not bother me, not scratched and did not grow up, but as a doctor I am seriously concerned for themselves. I decided to be screened in Israel, as a doctor, I know that in Israeli hospitals medicine better I had a biopsy and was diagnosed -. basal cell carcinoma, the most common form of skin cancer After collecting all the analysis I was assigned operation I removed the tumor and tissue around it, so as not.. to leave any of the cancer cell With this method the tissue is removed layer by layer and checked under the microscope My surgery lasted half -.. day and no complications were not Today, on the nose scar barely visible, that too can not but. rejoice. Ironically, I became a patient of his professional coll eagues. Three years later, another unusual pimple appeared on the cheek under the eye. At this time, I immediately turned to trusted professionals in Israel. I again had surgery and was told why I had a relapse. In my youth I was involved in swimming and I have often had a sunburn on the skin, plus I loved the solarium. Now I advise patients not to neglect health and protect the skin from the sun. Thanks to Israeli doctors, who conducted the diagnosis and surgery! "Elena, Moscow.


The form Submitting the this by you agree to the privacy policy


No comments yet

new comment


definitely (will not be published)